Related Experiment Video
Updated: Jul 14, 2026

Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat
Published on: August 28, 2021
Use of dexmedetomidine in patients with trisomy 21 after cardiac surgery
M Kalyanaraman1, J L Costello, J P Starr
1Children's Hospital of New Jersey, C-5, 201 Lyons Avenue, Newark, NJ 07112, USA. mkalyanaraman@sbhcs.com
Insights
Children with trisomy 21 often need more sedation after heart surgery. Dexmedetomidine, an alpha-2 adrenergic agonist, was successfully used for sedation in these patients, offering a potential new option.
Area of Science:
- Pediatric Cardiology
- Anesthesiology
- Genetics
Background:
- Children with trisomy 21 (Down syndrome) exhibit a high prevalence of congenital heart disease (CHD).
- Surgical repair of CHD in trisomy 21 patients often necessitates significant postoperative sedation.
- Standard sedative regimens may require higher doses or multiple agents in this population.
Observation:
- Dexmedetomidine is an alpha-2 adrenergic receptor agonist with known sedative, analgesic, and anxiolytic effects.
- The study investigated the utility of dexmedetomidine in the postoperative management of trisomy 21 patients undergoing CHD repair.
Findings:
- Successful administration of dexmedetomidine was achieved in pediatric patients with trisomy 21 post-congenital heart surgery.
- This suggests dexmedetomidine can be an effective sedative agent in this specific patient group.
Implications:
- Dexmedetomidine may offer a viable alternative for postoperative sedation in trisomy 21 patients with CHD.
- Further research could explore optimal dosing and long-term outcomes of dexmedetomidine use in this population.
- This finding could improve pain and anxiety management, potentially reducing the need for higher-dose or multiple sedatives.
Abstract:
Children with trisomy 21 have a high incidence of congenital heart disease that frequently requires surgical repair. These patients often require multiple and higher dosage sedatives during the postoperative period. Dexmedetomidine is an alpha(2)-adrenergic receptor agonist that has sedative, analgesic, and anxiolytic properties. We report the successful use of dexmedetomidine in patients with trisomy 21 following surgical repair of congenital heart disease.
Related Concept Videos
Parenteral Anesthetics: Overview
Depolarizing Blockers: Pharmocokinetics
Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
